NERVGEN PHARMA CORP (NGEN.V) Financials
NGEN.V Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 16.4 million | 11.3 million |
| 2023-06-30 | 17.4 million | 9.9 million |
| 2023-03-31 | 19.1 million | 9.2 million |
| 2022-12-31 | 23.9 million | 10.4 million |
NGEN.V Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.6 million | 1.8 million |
| 2023-06-30 | -2.0 million | 2.2 million |
| 2023-03-31 | -4.8 million | 736779 |
| 2022-12-31 | -5.1 million | 537118 |
NGEN.V Net Income
No data available :(
NGEN.V Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | - | - | 219242 |
| 2023-06-30 | - | - | 240968 |
| 2023-03-31 | - | - | 262370 |
| 2022-12-31 | - | - | 283455 |
NGEN.V Shares Outstanding
NGEN.V Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 138459 | 837574 | 2.6 million | - |
| 2023-06-30 | 2944 | 1.5 million | 3.2 million | - |
| 2023-03-31 | 2944 | 3.0 million | 1.7 million | - |
| 2022-12-31 | 2944 | 5.1 million | 1.7 million | - |
NGEN.V Cost of Revenue
No data available :(
NGEN.V
Price: CA$2.05
52 week price:
Earnings Per Share: -0.33 CAD
P/E Ratio: -11.42
Exchange: VAN
Sector: Healthcare
Industry: Biotechnology
Volume: 70700
Market Capitalization: 131.5 million